ClinicalTrials.gov
ClinicalTrials.gov Menu

HD16 for Early Stage Hodgkin Lymphoma (HD16)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00736320
Recruitment Status : Active, not recruiting
First Posted : August 15, 2008
Last Update Posted : May 3, 2017
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Andreas Engert, University of Cologne

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : May 2020
  Estimated Study Completion Date : May 2020